Harnessing Nature's Pharmacy: Investigating Natural Compounds As Novel Therapeutics for Ulcerative Colitis

Overview

Journal Front Pharmacol

Date 2024 Aug 29

PMID 39206263

Authors

You Huang

Qiuhong Wu

Sha Li

Xia Lin

Shasha Yang

Rui Zhu

Chaomei Fu

Zhen Zhang

Affiliations

Soon will be listed here.

Abstract

Backgrounds: Ulcerative colitis (UC) is a form of chronic inflammatory bowel disease, and UC diagnosis rates continue to rise throughout the globe. The research and development of new drugs for the treatment of UC are urgent, and natural compounds are an important source. However, there is a lack of systematic summarization of natural compounds and their mechanisms for the treatment of UC.

Methods: We reviewed the literature in the databases below from their inception until July 2023: Web of Science, PubMed, China National Knowledge Infrastructure, and Wanfang Data, to obtain information on the relationship between natural compounds and UC.

Results: The results showed that 279 natural compounds treat UC through four main mechanisms, including regulating gut microbiota and metabolites (Mechanism I), protecting the intestinal mucosal barrier (Mechanism II), regulating intestinal mucosal immune response (Mechanism III), as well as regulating other mechanisms (Mechanism Ⅳ) such as cellular autophagy modulation and ferroptosis inhibition. Of these, Mechanism III is regulated by all natural compounds. The 279 natural compounds, including 62 terpenoids, 57 alkaloids, 52 flavonoids, 26 phenols, 19 phenylpropanoids, 9 steroids, 9 saponins, 8 quinonoids, 6 vitamins, and 31 others, can effectively ameliorate UC. Of these, terpenoids, alkaloids, and flavonoids have the greatest potential for treating UC. It is noteworthy to highlight that a total of 54 natural compounds exhibit their therapeutic effects by modulating Mechanisms I, II, and III.

Conclusion: This review serves as a comprehensive resource for the pharmaceutical industry, researchers, and clinicians seeking novel therapeutic approaches to combat UC. Harnessing the therapeutic potential of these natural compounds may significantly contribute to the improvement of the quality of life of patients with UC and promotion of disease-modifying therapies in the future.

Citing Articles

Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways.

Gong S, Xu R, Wang Y, Mao S, Zhang Y, Bu Q Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005956 PMC: 11858545. DOI: 10.3390/ph18020141.

References

Lv Q, Xing Y, Liu Y, Chen Q, Xu J, Hu L . Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation. Pharmacol Res. 2021; 169:105613. DOI: 10.1016/j.phrs.2021.105613. View

Jia L, Xue K, Liu J, Habotta O, Hu L, Abdel Moneim A . Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways. Mediators Inflamm. 2020; 2020:9419085. PMC: 7542536. DOI: 10.1155/2020/9419085. View

Aoyagi Y, Nagata S, Kudo T, Fujii T, Wada M, Chiba Y . Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis. Pediatr Int. 2010; 52(5):729-34. DOI: 10.1111/j.1442-200X.2010.03195.x. View

Gu P, Zhu L, Liu Y, Zhang L, Liu J, Shen H . Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int Immunopharmacol. 2017; 50:152-160. DOI: 10.1016/j.intimp.2017.06.022. View

Zhu L, Xu L, Zhao S, Shen Z, Shen H, Zhan L . Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol. 2020; 104(12):5449-5460. DOI: 10.1007/s00253-020-10527-w. View

Zhang W, Yang Y, Su X, Xu D, Yan Y, Gao Q . Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice. Saudi J Gastroenterol. 2016; 22(6):448-455. PMC: 5184746. DOI: 10.4103/1319-3767.195552. View

Chen L, Liu D, Mao M, Liu W, Wang Y, Liang Y . Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory Pyroptosis. Mol Nutr Food Res. 2022; 66(22):e2200341. DOI: 10.1002/mnfr.202200341. View

Huang B, Wang L, Liu M, Wu X, Lu Q, Liu R . The underlying mechanism of A-type procyanidins from peanut skin on DSS-induced ulcerative colitis mice by regulating gut microbiota and metabolism. J Food Biochem. 2022; 46(7):e14103. DOI: 10.1111/jfbc.14103. View

Qu L, Shi K, Xu J, Liu C, Ke C, Zhan X . Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis. Phytomedicine. 2022; 98:153945. DOI: 10.1016/j.phymed.2022.153945. View

10.

Li T, Zhang J, Fei S, Zhu S, Zhu J, Qiao X . Glutamate microinjection into the hypothalamic paraventricular nucleus attenuates ulcerative colitis in rats. Acta Pharmacol Sin. 2013; 35(2):185-94. PMC: 4651215. DOI: 10.1038/aps.2013.140. View

11.

Pang B, Jin H, Liao N, Li J, Jiang C, Shi J . Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota-dependent manner. Food Res Int. 2021; 148:110568. DOI: 10.1016/j.foodres.2021.110568. View

12.

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

13.

Wu X, Yang Y, Dou Y, Ye J, Bian D, Wei Z . Arctigenin but not arctiin acts as the major effective constituent of Arctium lappa L. fruit for attenuating colonic inflammatory response induced by dextran sulfate sodium in mice. Int Immunopharmacol. 2014; 23(2):505-15. DOI: 10.1016/j.intimp.2014.09.026. View

14.

Peng L, Gao X, Nie L, Xie J, Dai T, Shi C . Astragalin Attenuates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting NF-κB Activation in Mice. Front Immunol. 2020; 11:2058. PMC: 7523281. DOI: 10.3389/fimmu.2020.02058. View

15.

Su C, Wen X, Bailey S, Jiang W, Rangwala S, Keilbaugh S . A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest. 1999; 104(4):383-9. PMC: 408529. DOI: 10.1172/JCI7145. View

16.

Chen Y, Zhang X, Yu C, Huang S, Xie Y, Dou X . Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways. Mol Med Rep. 2019; 20(2):1321-1332. PMC: 6625425. DOI: 10.3892/mmr.2019.10345. View

17.

Islam J, Sato S, Watanabe K, Watanabe T, Ardiansyah , Hirahara K . Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J Nutr Biochem. 2017; 42:43-50. DOI: 10.1016/j.jnutbio.2016.12.019. View

18.

Yin S, Yang H, Tao Y, Wei S, Li L, Liu M . Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response. Inflammation. 2020; 43(2):765-776. DOI: 10.1007/s10753-019-01164-1. View

19.

Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh H, Kutbi H . The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1α/miR-143 signalling. Basic Clin Pharmacol Toxicol. 2022; 131(5):406-419. DOI: 10.1111/bcpt.13788. View

20.

Hou Y, Chu C, Ko T, Yeh C, Yeh S . Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium. Eur J Nutr. 2012; 52(3):1089-98. DOI: 10.1007/s00394-012-0416-3. View